New England Journal of Medicine publishes pivotal cemiplimab trials showing positive results in advanced cutaneous squamous cell carcinoma
Patients treated with cemiplimab experienced robust anti-tumor effects
Data also presented today at the 2018 ASCO Annual Meeting
Cemiplimab applications unde...
Continue Reading →
